Lessons From DOJ's Handling Of Rare Medicare Fraud Case

Lessons From DOJ's Handling Of Rare Medicare Fraud Case

Publication

In an expert analysis published by Law360, Partners Ericka Aiken and Kevin Lamb, and Associate Charlotte Mostertz discuss the US Department of Justice's (DOJ) recently announced criminal indictment related to the Medicare Advantage program and point to the importance of functioning compliance programs.

Excerpt: "Indeed, the DOJ has said recently that it will increase the number of investigations into Medicare Advantage fraud. Heightened scrutiny may result in additional criminal prosecutions of individuals and even companies alongside increased civil enforcement. HealthSun is also the latest example of a company benefiting from declination under the DOJ's public commitment to providing incentives for voluntary self-disclosure and swift remediation."

HealthSun Health Plans Inc., allegedly falsified diagnoses submitted to the Centers for Medicare and Medicaid Services, leading to millions of dollars in overpayments. In this case, the DOJ declined to prosecute HealthSun based on its timely self-disclosure, cooperation and remediation efforts. Aiken, Lamb and Mostertz highlight the DOJ's focus on combating fraud in the Medicare Advantage program and the importance of the ability to detect and address potential risks to a company, including employee misconduct, promptly and effectively.

Read the full article.

 

Authors

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.